Microbiome and metabolome features in inflammatory bowel disease via multi-omics integration analyses across cohortsLijun Ning, Jie Hong, Jinmei Ding et al.|Nature Communications|2023Cited by 231
Multi-kingdom gut microbiota analyses define bacterial-fungal interplay and microbial markers of pan-cancer immunotherapy across cohortsXiaowen Huang, Haoyan Chen, Muni Hu et al.|Cell Host & Microbe|2023Cited by 82
Interplay between gut microbial communities and metabolites modulates pan-cancer immunotherapy responsesXiaoqiang Zhu, Haoyan Chen, Muni Hu et al.|Cell Metabolism|2025Cited by 56
A specific enterotype derived from gut microbiome of older individuals enables favorable responses to immune checkpoint blockade therapyXiaoqiang Zhu, Haoyan Chen, Xiaowen Huang et al.|Cell Host & Microbe|2024Cited by 35
Commensal bacteria promote azathioprine therapy failure in inflammatory bowel disease via decreasing 6-mercaptopurine bioavailabilityYuqing Yan, Jie Hong, Zhenhua Wang et al.|Cell Reports Medicine|2023Cited by 22